Form 4: Core Scientific Executive Receives RSU Grant
Statement of Changes in Beneficial Ownership
Chief Legal and Administrative Officer Todd DuChene was granted 138,547 restricted stock units as part of an annual award.
Summary
- Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc. (CORZ), received a grant of 138,547 restricted stock units (RSUs).
- The transaction occurred on May 20, 2026.
- Following this grant, the reporting person's total beneficial ownership of common stock increased to 2,098,895 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that does not signal a change in company strategy or financial health.
Positives
- The grant aligns executive compensation with long-term shareholder interests through equity-based incentives.
- The reporting person maintains a significant ownership stake of over 2 million shares, indicating strong alignment with company performance.
Negatives
- The issuance of new RSUs results in potential future dilution for existing shareholders upon vesting.
Risks
- Vesting of the RSUs is contingent upon the reporting person's continued service to the issuer, creating potential retention risk if the executive departs.
Future Outlook
The RSUs vest in one-third increments on March 15, 2027, followed by eight substantially equal quarterly installments, subject to continued service.
Management Comments
- The filing identifies Todd DuChene as the Chief Legal and Administrative Officer.
Industry Context
StockSavvy.ai notes that equity grants for C-suite executives are standard practice in the high-growth digital asset and infrastructure sector to ensure leadership retention and performance alignment.
Comparison to Industry Standards
- The use of multi-year vesting schedules for RSU grants is consistent with standard corporate governance practices for publicly traded technology and infrastructure companies.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual vesting and settlement of these RSUs.
Next Steps
- Vesting of the first tranche of RSUs on March 15, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Date of the RSU grant transaction. |
| 05/22/2026 | Date the Form 4 was signed and filed. |
| 03/15/2027 | Initial vesting date for one-third of the granted RSUs. |
Keywords
Core Scientific, CORZ, Insider Trading, Form 4, Executive Compensation, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.